TAKARA BIO INC. Logo

TAKARA BIO INC.

Provides life science research tools, gene therapies, and CDMO services for improving human health.

4974 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
草津市野路東七丁目4番38号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Takara Bio Inc. is a global biotechnology company dedicated to improving human health through innovative life science research tools and gene therapies. The company supplies a comprehensive portfolio of reagents, kits, instruments, and services to researchers focused on gene discovery, regulation, and function. Its offerings support a wide range of applications, including single-cell analysis, sequencing, immune profiling, and stem cell research. Additionally, Takara Bio is a key player in the development of cutting-edge medical technologies, focusing on gene and cell therapies for cancer and other diseases. The company also provides contract development and manufacturing (CDMO) services, supporting partners in the production of therapeutic products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-30 02:46
Post-Annual General Meeting Information
臨時報告書
Japanese 27.5 KB
2025-06-20 07:27
Registration Form
確認書
Japanese 8.1 KB
2025-06-20 07:26
Governance Information
内部統制報告書-第23期(2024/04/01-2025/03/31)
Japanese 23.6 KB
2025-06-20 07:24
Annual Report
有価証券報告書-第23期(2024/04/01-2025/03/31)
Japanese 1.7 MB
2025-05-13 09:11
Board/Management Information
臨時報告書
Japanese 21.8 KB
2024-11-11 02:37
Regulatory News Service
確認書
Japanese 8.1 KB
2024-11-11 02:36
Interim Report
半期報告書-第23期(2024/04/01-2025/03/31)
Japanese 167.8 KB
2024-07-01 04:07
Post-Annual General Meeting Information
訂正臨時報告書
Japanese 36.9 KB
2024-06-28 04:30
Post-Annual General Meeting Information
臨時報告書
Japanese 27.3 KB
2024-06-27 06:14
Governance Information
内部統制報告書-第22期(2023/04/01-2024/03/31)
Japanese 22.7 KB
2024-06-27 06:13
Registration Form
確認書
Japanese 8.1 KB
2024-06-27 06:12
Annual Report
有価証券報告書-第22期(2023/04/01-2024/03/31)
Japanese 1.8 MB
2024-02-14 07:42
Regulatory News Service
確認書
Japanese 8.1 KB
2024-02-14 07:40
Quarterly Report
四半期報告書-第22期第3四半期(2023/10/01-2023/12/31)
Japanese 162.6 KB
2023-11-10 02:13
Regulatory News Service
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all TAKARA BIO INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for TAKARA BIO INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
bioMérieux Logo
Provides in vitro diagnostic solutions for clinical and industrial microbiology.
France BIM
BioPorto Logo
IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.
Denmark BIOPOR
Biosergen AB Logo
Developing novel antifungal drugs for life-threatening infections in immunocompromised patients.
Sweden BIOSGN
Bio Solution Co.,Ltd. Logo
Develops cell therapies for degenerative diseases and supplies bio-lab reagents for R&D.
South Korea 086820
Biosynex Logo
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
France ALBIO
Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany BIO3
Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland BIOV

Talk to a Data Expert

Have a question? We'll get back to you promptly.